INTRODUCTION 1
The balance hypothesis asserts that the stoichiometric relationship among 2 subunits of a protein complex is essential for the survival and proliferation of cells; 3 the disruption of this relationship perturbs functions of protein complexes and 4 sometimes even causes cytotoxicity (1-8). The balance hypothesis provides a unique 5 framework for understanding a variety of biological phenomena, especially the 6 proliferation rate of aneuploid cells and the fate of duplicated genes. Aneuploidy, 7 defined as a karyotype that is not a multiple of the haploid complement, generates 8 dosage imbalance among genes on different chromosomes. Consistent with the 9 balance hypothesis, aneuploidy often results in a more severe growth defect than a 10 whole genome duplication that keeps the dosage balance among genes (5, 9). 11
Furthermore, the addition of a larger chromosome, which leads to a dosage imbalance 12 among more genes, often results in a greater reduction in fitness (6, 10-13). Gene 13 duplication confers the second type of dosage imbalance, between duplicate genes and 14 singletons. Consistent with the balance hypothesis, genes often reduce their 15 expression soon after duplication (14), through which the dosage balance is restored. 16
Furthermore, genes encoding protein complexes exhibit a higher retention rate after 17 the whole genome duplication so that the dosage balance among subunits is 18 maintained (2, 15). 19
A probably more prevalent but less studied source of dosage imbalance is caused 20 by DNA replication that occurs each cell cycle. During the DNA synthesis phase (S 21 phase) of a cell cycle, the genome is replicated in a defined temporal order known as 22 the replication-timing program (16, 17) . In the middle of S phase, early-replicating 23 genes have doubled their copy number, but late-replicating genes have not, leading to 24 a dosage imbalance between early and late-replicating genes (Fig. 1A) . Such dosage 25 imbalance likely causes a growth defect especially among genes sensitive to dosage 26 relationship such as those encoding the same protein complex (2, 6). Although 27 acetylated histones (H3K56ac) can incorporate into newly replicated DNA regions 28 and partly suppress the expression of newly replicated genes in yeast (18, 19) , this 29 compensatory mechanism cannot completely restore the dosage balance; the mRNA 30 levels of early-replicating genes still exhibited a ~20% increase compared to late-31 replicating genes during the mid-S phase (18). Consistent with this, a GFP reporter 32 inserted into early-replicating regions in yeast exhibits higher expression (20) . 33
The dosage imbalance during S phase could be severer in mammalian cells where 34 DNA replication lasts longer (~8 hours) each cell cycle. An exacerbating factor is that 1 H3K56ac may not mark newly replicated DNA in mammalian cells (21). Consistently, 2 in mouse embryonic stem cells (ESCs), the transcription rates of Oct4 and Nanog 3 increased by 28% and 50%, respectively, upon DNA replication (22). These data show 4 that replication can cause dosage imbalance during S phase, and suggest that 5 additional mechanisms should exist in mammalian cells to solve the problem. Here, 6
we proposed a hypothesis that the replication of genes encoding the same protein 7 complex is synchronized during S phase so that the dosage balance is warranted. 8
Indeed, we observed a synchronized replication within protein complexes, but 9 surprisingly, only in fast-proliferating cells such as various tumor cells, indicating a 10 convergent evolution towards synchronized replication during tumorigenesis. 11
12

RESULTS
13
Genes encoding subunits of the same protein complex tend to replicate 14
simultaneously in HeLa cells 15
The synchronized replication hypothesis predicts a reduced variation in 16 replication timing among genes encoding the same protein complex. Indeed, genes 17 encoding some protein complexes are replicated almost simultaneously in HeLa cells 18 as exemplified in Fig. 2A . To test this prediction at the genomic scale, we retrieved 19 the components of 1,521 protein complexes from the Human Protein Reference 20 Database (23) and the replication-timing program of HeLa cells (24). For each protein 21 complex, we calculated the standard deviation of replication timing of all genes 22 encoding the protein complex (Fig. 2B) . As a control, we randomly sampled genes 23 from the genome to constitute "pseudo" protein complexes, keeping the number of 24 complexes and the number of subunits in each complex unchanged (Fig. 2B) . We 25 performed the random sampling 1,000 times. The median of observed standard 26 deviations is significantly smaller than the random expectation (P < 0.001, 27 permutation test, Fig. 2B ), indicating synchronized replication within protein 28 complexes. The same conclusion can be reached when we shuffled among genes 29 encoding protein complexes to constitute "pseudo" protein complexes (P < 0.001, 30 permutation test, Fig. 2C) . 31
It is worth noting that genes encoding the same protein complex tend to form 32 clusters on chromosomes (25, 26), which are likely to simultaneously replicate 33 because they have similar physical distances to the closest replication origin. To 1 determine if the smaller variation in replication timing within a protein complex is 2 fully explained by such gene clusters, we discarded protein complexes of which at 3 least two subunits are encoded by the genes on the same chromosome. The smaller 4 standard deviation of replication timing within a protein complex remained observed 5 (P = 0.002, permutation test, Fig. S1 ). 6
Synchronized replication occurs only in fast-proliferating cells 7
The replication-timing program varies among cell types. To determine if 8 synchronized replication occurs uniformly among various human cells, we retrieved 9 the replication-timing programs previously reported in 17 cell lines/types (24, 27). 10
They include 6 human ESC lines, 5 cancer cell lines, and 6 differentiated cell types 11 such as liver and pancreas cells derived from human ESCs (Fig. 3A) . The 12 proliferation of ESCs and cancer cells is fast whereas that of differentiated cells is 13 slow (28). These cell lines/types exhibit various levels of synchronized replication 14 within protein complexes (as exemplified in Fig. 3B ). To assess synchronized 15 replication at the genomic scale, we randomly shuffled genes encoding protein 16 complexes ( Fig. S2 , with three examples shown in Fig. 3C ). We used the P value of 17 the permutation test to infer the level of synchronized replication in each cell line/type 18 and labeled synchronized replication for those with P < 0.05 (Fig. 3E) . Surprisingly, 19 synchronized replication was exclusively observed in the 11 fast-proliferating cell 20 lines ( Fig. 3D-E 
Synchronized replication is evolved convergently during tumorigenesis 34
Since cancer cells are "evolved" from various differentiated cells rather than 1
ESCs. Consistently, ESCs and cancer cells did not form a monophyletic group (Fig  2   3D ) when we clustered cell lines/types based on the similarity of their replicating-3 timing programs. Instead, four out of the five cancer cell lines were clustered with 4 primitive hepatocytes and pancreatic endoderm cells, echoing their evolutionary 5 origin of differentiated cells. Nevertheless, the replication-timing programs of these 4 6 cancer cell lines permit synchronized replication whereas those of primitive 7 hepatocytes and pancreatic endoderm cells do not (Fig. 3D) . More intriguingly, a 8 human colon cancer cell line, HCT116, has a very different replication-timing 9
program from all other cell types but exhibits the pattern of synchronized replication 10 (Fig. 3D) . Collectively, these observations suggest convergent cellular evolution 11 during tumorigenesis to optimize the replication-timing program for fast proliferation. 12
Differentiated cells lose synchronized replication mainly through a replication 13 delay 14
To investigate the molecular mechanism by which synchronized replication is lost 15 in differentiated cells, we identified 165 protein complexes in which the standard 16 deviation of replication timing among subunits was significantly increased during 17 differentiation (P < 0.05 in the t-tests, an example is shown in Fig. 3B ). For each of 18 the 491 genes encoding these protein complexes, we calculated the average 19 replication timing among ESCs and differentiated cells, respectively (Fig. 4A) . 20
Among these genes, 92% exhibited a delay in replication in differentiated cells (top in 21 . 3B) . Presumably, the 32 restoration could occur either through i) reversing the change in replication timing 33 during cell differentiation or ii) through an intergenic suppression that the replication 34 timing of a second gene in the same protein complex follows that of the first. We 1 found that during tumorigenesis, 82% genes reversed the changes during cell 2 differentiation (an example is shown in Fig. 4C ), significantly higher than the fraction 3 (72%) among genes not encoding protein complexes (bottom in Fig. 4B , odds ratio = 4 1.7, P = 7×10 -4 , the Fisher's exact test). Consistently, when we clustered the 17 cell 5 types/lines with the replication timing of the genes encoding these 79 protein 6 complexes, ESCs and cancer cells become closer in the dendrogram (Fig. S3) . 7
DISCUSSION 8
Abnormal replication-timing programs have been known to be related to disease 9 and cancer (30-32). Our study provides a mechanism why a proper regulation of the 10 replication-timing program is essential, especially for fast-proliferating cells: to 11 maintain the dosage balance between early and late-replicating genes during S phase. 12
We observed a convergent cancer evolution of replication-timing program toward 13
ESCs, echoing previous analyses on the evolution of tumor cells at different levels, 14 such as those at the transcriptome or the amino acid usage level (33-35). 15
We showed that the demand for dosage balance during S phase could cause 16 synchronized replication of genes encoding the same protein complex. However, such 17 synchronized replication could also have evolved under other selection pressures. For 18 example, it may evolve to meet the demand for similar expression levels of genes 19 encoding the same protein complex because replication timing is associated with gene 20 expression level (36, 37). Nevertheless, this mechanism cannot explain why 21 synchronized replication is lost in differentiated cells, where the genes encoding 22 protein complexes remain expressed (Fig. S4) and the dosage balance among subunits 23 remains important (Fig. S5) . The selection for dosage balance during S phase 24 uniquely predicts the loss of synchronized replication in slow-proliferating cells and 25 the re-gain of it in cancer cells. 26
The synchronized replication of complex members is restored in cancer cells, 27 although the number of mutations bared in each cancer cell is usually small (38). It is 28 therefore unlikely that each complex restores the synchronized replication through 29 individual mutations on its members during tumorigenesis. Master regulators of the 30 replication-timing program exist which control the firing of multiple replication 31 origins (39). In principle, the "switching" back of such master regulators to the ESC 32 status could make cancer cells rapidly restored synchronized replication. Consistently, 33 the re-gain of synchronized replication in cancer cells is mainly through reversing the 34 changes in replication timing during cell differentiation (bottom in Fig. 4B) . 1 Whereas the dosage imbalance during S phase can be partly relieved by the 2 H3K56ac-associated transcription repression of newly replicated genes in yeast, the 3 balance is not completely restored; early-replicating genes still exhibit a ~20% higher 4 expression level during the mid-S phase (18) (Fig. S1 ), yet the gene cluster itself could, in turn, be an evolutionary 25 outcome of the selection for the dosage balance during S phase. Replication origins 26 fire stochastically at the single-cell level (47). Therefore, the synchronization of 27 replication timing is not robust in individual cells when these genes are interspersed in 28 the genome and use the different replication origins. Forming a gene cluster is a more 29 robust strategy for maintaining a dosage-sensitive relationship among genes. 30
Our results also have implications for DNA sequence evolution. For example, 31 since replication timing is a major determinant of mutation rate (48, 49), we predict 32 that genes encoding the same protein complex will have similar mutation rates due to 33 synchronized replication. Consistently, it was reported that the evolutionary rate 34 coevolves between a pair of genes that share a biological function or are co-expressed 1 (50). Collectively, our study not only identifies the driving forces underlying the 2 evolution of the replication-timing program but also provides new insights into the 3 evolution of DNA sequences. 4
5
METHODS 6
Data retrievals 7
The information of 1,521 protein complexes in humans was downloaded from the 8 Human Protein Reference Database (HPRD) release 9 (www.hprd.org). Among them, 9 1,317 were annotated completely and were used in this study. Chromosomal locations 10 of these genes were retrieved from Ensembl release 87 (www.ensembl.org). 11
The replication-timing profiles used in this study were downloaded from the 12
ReplicationDomain database (24) (https://www2.replicationdomain.com/) and are 13 listed in Table S1 . Below we briefly describe how the experiments were done to 14 obtain the replication timing data. Detailed methods are in two previous studies (51, 15 52). Growing cells were pulse-labeled with bromodeoxyuridine (BrdU) for 1-2 hours, 16 fixed, and then labeled with propidium iodide. Labeled cells were separated by 17 fluorescence-activated cell sorter (FACS) into early and late-S bins. DNA with BrdU-18 incorporation was immunoprecipitated, differentially labeled, and co-hybridized to a 19 microarray. The log2-transformed (early/late) ratio of the intensity of each probe was 20 used to generate a replication-timing profile for the entire genome. 21
Gene expression data used in this study were downloaded from NCBI Gene 22
Expression Omnibus (GEO) and are listed in Table S1 . 23
Estimation of gene replication timing 24
The list of 19,805 protein-coding genes was retrieved from human GRCh38.p12 25 annotation file that was downloaded from Ensembl 26 (http://asia.ensembl.org/index.html). The average replication-timing ratio of probes 27 having overlap with each gene was defined as the replication timing of this gene. 28
Estimation of the proliferation rate with gene expression profiles 29
PCNA is a component of DNA polymerase δ and its expression level is a reporter 30 of DNA synthesis. We defined a panel of 11 meta-PCNA genes whose expression is 31 positively correlated with PCNA. Specifically, we normalized the average expression 1 level of genes (log2(RPKM+1)) in 17 cell lines/types and calculated the Pearson's 2 correlation between PCNA and each of 131 previously identified candidate meta-3 PCNA genes. Genes with correlation coefficients greater than 0.9 were defined as 4 meta-PCNA genes in this study (PCNA, ZWINT, RFC3, LBR, TFDP1, SNRPB, SMC4, 5 NUSAP1, BIRC5, UBE2C, and TROAP). The proliferation rate was inferred from the 6 average expression level (log2(RPKM+1)) of the 11 meta-PCNA genes (29). 7
Estimation of the fraction of cells in S phase with flow-cytometry 8
Flow-cytometry data of propidium iodide-stained cells in 7 cell lines/types (listed 9
in Table S1 ) were generated in a previous study (27) . We estimated the fraction of 10 cells belongs to one of the three stages in the cell cycle (G1, S, and G2/M) using 11
FlowJo. 12
Clustering of cell lines/types 13
The clustering of cell lines was performed with the function hclust in R. The 14 Ward's method was used. 15
Loess smoothed replication-timing profiles 16
We combined the log2-transformed ratios (early/late) of the intensity of each 17 probe for each of the three cell types (ESCs, differentiated cells, and cancer cells). 18
The function loess.smooth in R was used to generate a smoothed profile (Fig. 4C)  19 with the parameters span = 1/200 and evaluation = 2,000. 20
Code availability 21
All codes to analyze the data and generate figures are available at 22 https://github.com/YingChen10/Synchronized-replication-during-S-phase. 
